Details for New Drug Application (NDA): 022066
✉ Email this page to a colleague
The generic ingredient in OMNISCAN is gadodiamide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the gadodiamide profile page.
Summary for 022066
Tradename: | OMNISCAN |
Applicant: | Ge Healthcare |
Ingredient: | gadodiamide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 14.35GM/50ML (287MG/ML) | ||||
Approval Date: | Sep 5, 2007 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 28.7GM/100ML (287MG/ML) | ||||
Approval Date: | Sep 5, 2007 | TE: | RLD: | Yes |
Expired US Patents for NDA 022066
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-001 | Sep 5, 2007 | 5,560,903 | ⤷ Subscribe |
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-002 | Sep 5, 2007 | 5,362,475 | ⤷ Subscribe |
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-002 | Sep 5, 2007 | 5,560,903 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription